Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Viruses (13:10) - Basel : MDPI - Art.-Id. 1918
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Technische Universität Berlin
- (wann)
-
2021
- Urheber
-
Hazini, Ahmet
Dieringer, Babette
Klingel, Karin
Pryshliak, Markian
Geisler, Anja
Kobelt, Dennis
Daberkow, Ole
Kurreck, Jens
Linthout, Sophie van
Fechner, Henry
- DOI
-
10.14279/depositonce-12483
- Handle
-
11303/13707
- URN
-
urn:nbn:de:101:1-2021101301590387761159
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hazini, Ahmet
- Dieringer, Babette
- Klingel, Karin
- Pryshliak, Markian
- Geisler, Anja
- Kobelt, Dennis
- Daberkow, Ole
- Kurreck, Jens
- Linthout, Sophie van
- Fechner, Henry
- Technische Universität Berlin
Entstanden
- 2021
Ähnliche Objekte (12)
Coxsackievirus B3—Its Potential as an Oncolytic Virus
Development of recombinant oncolytic Coxsackievirus B3 for treatment of colorectal carcinoma
Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines
Oncolytic activity of a coxsackievirus B3 strain in patient-derived cervical squamous cell carcinoma organoids and synergistic effect with paclitaxel
Viral Oncolytic Therapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic virotherapy of glioblastoma
Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21
Identifizierung neutralisierender Antigendeterminanten von Coxsackievirus B3 und Coxsackievirus B4
Oncolytic viruses for cancer immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic herpes simplex virus and immunotherapy
Coxsackievirus B3—Its Potential as an Oncolytic Virus
Development of recombinant oncolytic Coxsackievirus B3 for treatment of colorectal carcinoma
Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines
Oncolytic activity of a coxsackievirus B3 strain in patient-derived cervical squamous cell carcinoma organoids and synergistic effect with paclitaxel
Viral Oncolytic Therapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic virotherapy of glioblastoma
Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21
Identifizierung neutralisierender Antigendeterminanten von Coxsackievirus B3 und Coxsackievirus B4
Oncolytic viruses for cancer immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic herpes simplex virus and immunotherapy
Coxsackievirus B3—Its Potential as an Oncolytic Virus
Development of recombinant oncolytic Coxsackievirus B3 for treatment of colorectal carcinoma
Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines
Oncolytic activity of a coxsackievirus B3 strain in patient-derived cervical squamous cell carcinoma organoids and synergistic effect with paclitaxel
Viral Oncolytic Therapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic virotherapy of glioblastoma
Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21
Identifizierung neutralisierender Antigendeterminanten von Coxsackievirus B3 und Coxsackievirus B4
Oncolytic viruses for cancer immunotherapy
Perspectives on immunotherapy via oncolytic viruses